E1	Condition:T1 Name:T2
E3	Procedure:T3 Name:T4 Temporality:E2
E5	Procedure:T5 Name:T6
E7	Condition:T7 Name:T8 Polarity:T58
E9	Condition:T9 Name:T10
E11	Procedure:T11 Name:T12 Stability:T62 Temporality:E18
E13	Condition:T13 Name:T14
E15	Condition:T15 Name:T16
E17	Condition:T17 Name:T18
E19	Procedure:T19 Name:T20 Temporality:E52
E21	Procedure:T21 Name:T22
E23	Condition:T23 Name:T24 Stage:E34
E25	Condition:T25 Name:T26
E27	Condition:T27 Name:T28
E29	Condition:T29 Name:T30
E30	Eq-Comparison:T45 Operator:T31 Temporal-Unit:T37 Value:T39
E31	Eq-Comparison:T46 Operator:T32 Value:T40 Unit:T63 Per:T64
E32	Eq-Comparison:T47 Operator:T33 Value:T42 Unit:T78
E33	Eq-Comparison:T48 Operator:T35 Value:T43 Unit:T99 Per:T100 Per2:T101
E34	Eq-Comparison:T49 Operator:T36 Value:T44
E2	Eq-Comparison:T50 Temporal-Period:T51
E4	Modifier:T52 Modifies:T10
E6	Procedure:T53 Temporality:E30
E8	Study:T54 Temporality:E10
E10	Eq-Comparison:T55 Temporal-Recency:T56
E12	Temporal-Connection:T57 Arg:E30 Arg2:E8
E14	Temporal-Connection:T59 Arg:E15 Arg2:E5
E18	Eq-Comparison:T60 Temporal-Period:T61
E16	Drug:T65 Name:T66 Dose:E31 Duration:E22
E20	And:T67 Arg:E11 Arg2:E16
E22	Eq-Comparison:T68 Operator:T69 Value:T41 Temporal-Unit:T38
E24	Study:T70 Temporality:E26
E26	Eq-Comparison:T71 Temporal-Recency:T72
E28	Temporal-Connection:T73 Arg:E22 Arg2:E24
E35	Observation:T74 Name:T75
E36	Observation:T76 Name:T77 Eq-Comparison:E32
E37	Observation:T79 Name:T80 Eq-Comparison:E38
E38	Eq-Comparison:T81 Operator:T34 Unit:T82
E39	Eq-Comparison:T83 Temporal-Period:T84
E40	Drug:T85 Name:T86 Temporality:E39
E41	Drug:T87 Name:T88
E42	Or:T89 Arg:E40 Arg2:E41
E43	Observation:T90 Name:T91 Polarity:T92 Severity:T93
E44	And:T94 Arg:E1 Arg2:E13
E45	Observation:T95 Name:T96
E46	Observation:T97 Name:T98 Eq-Comparison:E33
E47	Modifier:T102 Modifies:T26
E48	Condition:T103 Name:T104
E49	And:T105 Arg:E48 Arg2:E27
E50	Condition:T106 Name:T107
E51	Or:T108 Arg:E29 Arg2:E17
E52	Eq-Comparison:T109 Temporal-Period:T115
E53	Condition:T110 Name:T111
E54	Condition:T112 Name:T113
E55	Or:T114 Arg:E53 Arg2:E54
E56	Exception:T116 From:E19 Except:E21
E57	Assertion:T117 Asserted:E58
E58	Procedure:T118 Name:T119
E59	Other:T120 Is-Other:E58
E60	Study:T121
E61	Temporal-Connection:T122 Arg:E58 Arg2:E60
T1	Condition 597 616	portal hypertension
T2	Condition-Name 597 616	portal hypertension
T3	Procedure 34 50	liver transplant
T4	Procedure-Name 34 50	liver transplant
T5	Procedure 181 197	liver transplant
T6	Procedure-Name 181 197	liver transplant
T7	Condition 137 162	polyneuropathy disability
T8	Condition-Name 137 162	polyneuropathy disability
T9	Condition 74 85	amyloidosis
T10	Condition-Name 74 85	amyloidosis
T11	Procedure 223 248	immunosuppressive regimen
T12	Procedure-Name 223 248	immunosuppressive regimen
T13	Condition 622 629	ascites
T14	Condition-Name 622 629	ascites
T15	Condition 164 167	PND
T16	Condition-Name 164 167	PND
T17	Condition 797 825	human immunodeficiency virus
T18	Condition-Name 797 825	human immunodeficiency virus
T19	Procedure 959 976	organ transplants
T20	Procedure-Name 959 976	organ transplants
T21	Procedure 988 1004	liver transplant
T22	Procedure-Name 988 1004	liver transplant
T23	Condition 841 881	New York Heart Association heart failure
T24	Condition-Name 841 881	New York Heart Association heart failure
T25	Condition 733 744	amyloidosis
T26	Condition-Name 733 744	amyloidosis
T27	Condition 769 780	hepatitis B
T28	Condition-Name 769 780	hepatitis B
T29	Condition 782 793	hepatitis C
T30	Condition-Name 782 793	hepatitis C
T31	Eq-Operator 86 87	≥
T32	Eq-Operator 254 255	≤
T33	Eq-Operator 367 368	≥
T34	Eq-Operator 397 418	greater than or equal
T35	Eq-Operator 683 684	≤
T36	Eq-Operator 900 901	>
T37	Eq-Temporal-Unit 90 96	months
T38	Eq-Temporal-Unit 294 300	months
T39	Eq-Value 87 89	12
T40	Eq-Value 255 257	10
T41	Eq-Value 292 293	3
T42	Eq-Value 368 370	70
T43	Eq-Value 684 686	30
T44	Eq-Value 901 902	2
T45	Eq-Comparison 86 96	≥12 months
T46	Eq-Comparison 254 264	≤10 mg/day
T47	Eq-Comparison 367 371	≥70%
T48	Eq-Comparison 683 702	≤30 mL/min/1.73 m^2
T49	Eq-Comparison 900 902	>2
T50	Eq-Comparison 25 33	Received
T51	Eq-Temporal-Period 25 33	Received
T52	Modifier 68 73	hATTR
T53	Procedure 55 64	treatment
T54	Study 104 109	study
T55	Eq-Comparison 110 115	start
T56	Eq-Temporal-Recency 110 115	start
T57	Temporal-Connection 97 103	before
T58	Polarity 125 133	increase
T59	Temporal-Connection 175 180	after
T60	Eq-Comparison 207 215	received
T61	Eq-Temporal-Period 207 215	received
T62	Stability 216 222	stable
T63	Eq-Unit 258 260	mg
T64	Eq-Temporal-Unit 261 264	day
T65	Drug 268 278	prednisone
T66	Drug-Name 268 278	prednisone
T67	And 249 253	with
T68	Eq-Comparison 283 300	at least 3 months
T69	Eq-Operator 283 291	at least
T70	Study 308 313	study
T71	Eq-Comparison 314 319	start
T72	Eq-Temporal-Recency 314 319	start
T73	Temporal-Connection 301 307	before
T74	Observation 329 357	Karnofsky Performance Status
T75	Observation-Name 329 357	Karnofsky Performance Status
T76	Observation 359 362	KPS
T77	Observation-Name 359 362	KPS
T78	Eq-Unit 370 371	%
T79	Observation 381 396	vitamin A level
T80	Observation-Name 381 396	vitamin A level
T81	Eq-Comparison 397 443	greater than or equal to lower limit of normal
T82	Eq-Unit 422 443	lower limit of normal
T83	Eq-Comparison 473 492	previously received
T84	Eq-Temporal-Period 473 492	previously received
T85	Drug 493 502	inotersen
T86	Drug-Name 493 502	inotersen
T87	Drug 506 515	patisiran
T88	Drug-Name 506 515	patisiran
T89	Or 503 505	or
T90	Observation 548 567	liver function test
T91	Observation-Name 548 567	liver function test
T92	Polarity 568 581	abnormalities
T93	Severity 536 547	significant
T94	And 617 621	with
T95	Observation 639 675	estimated glomerular filtration rate
T96	Observation-Name 639 675	estimated glomerular filtration rate
T97	Observation 677 681	eGFR
T98	Observation-Name 677 681	eGFR
T99	Eq-Unit 687 689	mL
T100	Eq-Temporal-Unit 690 693	min
T101	Eq-Unit 694 702	1.73 m^2
T102	Modifier 718 732	leptomeningeal
T103	Condition 754 763	infection
T104	Condition-Name 754 763	infection
T105	And 764 768	with
T106	Condition 827 830	HIV
T107	Condition-Name 827 830	HIV
T108	Or 794 796	or
T109	Eq-Comparison 950 958	received
T110	Condition 911 927	wheelchair bound
T111	Condition-Name 911 927	wheelchair bound
T112	Condition 931 940	bedridden
T113	Condition-Name 931 940	bedridden
T114	Or 928 930	or
T115	Eq-Temporal-Period 950 958	received
T116	Exception 977 987	other than
T117	Assertion 1010 1017	Will be
T118	Procedure 1033 1052	tetramer stabilizer
T119	Procedure-Name 1033 1052	tetramer stabilizer
T120	Other 1027 1032	other
T121	Study 1064 1069	study
T122	Temporal-Connection 1053 1059	during
A1	Eq-Operator-Value T31 GTEQ
A2	Eq-Operator-Value T32 LTEQ
A3	Eq-Operator-Value T33 GTEQ
A4	Eq-Operator-Value T34 GTEQ
A5	Eq-Operator-Value T35 LTEQ
A6	Eq-Operator-Value T36 GT
A7	Eq-Temporal-Unit-Value T37 month
A8	Eq-Temporal-Unit-Value T38 month
A9	Eq-Temporal-Period-Value T51 past
A10	Eq-Temporal-Recency-Value T56 first-time
A11	Temporal-Connection-Type-Value E12 before
A12	Polarity-Value T58 high
A13	Temporal-Connection-Type-Value E14 after
A14	Eq-Temporal-Period-Value T61 past
A15	Stability-Value T62 stable
A16	Eq-Temporal-Unit-Value T64 day
A17	Eq-Operator-Value T69 GTEQ
A18	Eq-Temporal-Recency-Value T72 first-time
A19	Temporal-Connection-Type-Value E28 before
A20	Observation-Type-Value T75 clinical-score
A21	Observation-Type-Value T80 lab
A22	Eq-Unit-Value T82 ref-range-normal
A23	Eq-Temporal-Period-Value T84 past
A24	Observation-Type-Value T91 lab
A25	Polarity-Value T92 abnormal
A26	Severity-Value T93 severe
A27	Observation-Type-Value T96 lab
A28	Observation-Type-Value T98 lab
A29	Eq-Temporal-Unit-Value T100 minute
A30	Eq-Temporal-Period-Value T115 past
A31	Assertion-Type-Value E57 hypothetical
A32	Temporal-Connection-Type-Value E61 during
R1	Using Arg1:E6 Arg2:E3
R2	Treatment-For Arg1:E6 Arg2:E9
R3	Abbrev-Of Arg1:E15 Arg2:E7
R4	Abbrev-Of Arg1:E36 Arg2:E35
R5	Abbrev-Of Arg1:E46 Arg2:E45
R6	Abbrev-Of Arg1:E50 Arg2:E17